Author

Matías G. De Vas

Imperial College London

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 3 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 3 Organism:mouse· 2 Assay:whole-genome sequencing· 2 Research Focus:differential expression· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Jorge P. FerreriD· 4 shared Anne Katrin LampeiD· 2 shared Anthony BeucheriD· 2 shared David MooreiD· 2 shared David ParryiD· 2 shared Goutham AtlaiD· 2 shared Inês CebolaiD· 2 shared Madapura M. PradeepaiD· 2 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersGenomics

Jorge P. FerrerORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintNov 14, 2022

Regulatory de novo mutations underlying intellectual disability

Matías G. De Vas, Fanny Boulet, Shweta S Joshi…·Santosh S. Atanur

This study identifies regulatory de novo mutations in fetal brain-specific enhancers as a significant contributor to intellectual disability.

DOI 10.1101/2022.11.14.22279410

humanwhole-genome sequencing

𝕏 PostBluesky

GenomicsbioRxivPreprintMay 12, 2021

HASTER is a transcriptional stabilizer of HNF1A

Anthony Beucher, Irene Miguel-Escalada, Diego Balboa…·Jorge P. Ferrer

This study identifies HASTER, a lncRNA that stabilizes HNF1A expression through cis-regulatory mechanisms, and shows its disruption leads to diabetes.

2 citations

𝕏 PostBluesky

GenomicsThe EMBO JournalPeer-reviewedMar 10, 2020

HNF1A recruits UTX to activate a differentiation program that suppresses pancreatic cancer

Mark Kalisz, Edgar Bernardo, Anthony Beucher…·Jorge P. Ferrer

This study shows HNF1A recruits UTX to activate a differentiation program that suppresses pancreatic cancer by remodeling enhancers and inhibiting oncogenic pathways.

77 citationstop 5%

mouseexperimental assay

𝕏 PostBluesky

GenomicsbioRxivPreprintSep 8, 2019

De novo variants in population constrained fetal brain enhancers and intellectual disability

Matías G. De Vas, Myles G. Garstang, Shweta S Joshi…·Santosh S. Atanur

The paper identifies de novo variants in fetal brain enhancers linked to intellectual disability by analyzing genomic data from affected individuals and their parents.

DOI 10.1101/621029

humanwhole-genome sequencing

𝕏 PostBluesky